Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Skin Diseases, Papulosquamous”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT03198390
What this trial is testing

Linking Epidermal Barrier Function With Anti-Oxidant Defense Mechanisms in Skin Conditions

Who this might be right for
Atopic DermatitisHidradenitis SuppurativaContact Dermatitis+1 more
University of Arizona 100
Not applicableUnknownNCT05925842
What this trial is testing

Clinical and Molecular Characterization of Axial Psoriatic Arthritis (PsA), A Pilot Study

Who this might be right for
Psoriatic Arthritis
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 40
Testing effectiveness (Phase 2)Study completedNCT00150982
What this trial is testing

Alefacept Mechanism of Action in Psoriasis

Who this might be right for
Psoriasis
University of Medicine and Dentistry of New Jersey 9
Post-approval studies (Phase 4)Study completedNCT00748020
What this trial is testing

Narrow-Band UVB-Therapy in Psoriasis

Who this might be right for
Psoriasis
Radboud University Medical Center 109
Testing effectiveness (Phase 2)Study completedNCT02322086
What this trial is testing

Cellular and Immunologic Changes in the Skin of Subjects Receiving PH-10

Who this might be right for
Psoriasis
Provectus Pharmaceuticals 30
Large-scale testing (Phase 3)UnknownNCT02701205
What this trial is testing

Safety and Efficacy Study of Etanercept (Qiangke®) to Treat Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque PsoriasisPsoriasis
Shanghai Celgen Bio-Pharmaceutical Co.,Ltd 216
Not applicableStudy completedNCT02626793
What this trial is testing

Otezla® in Patients With Plaque Psoriasis Under Routine Conditions

Who this might be right for
Psoriasis
Amgen 391
Not applicableUnknownNCT04275206
What this trial is testing

The Anti-inflammatory Effects of Harkány Medicinal Water

Who this might be right for
Rheumatoid ArthritisPsoriasis
University of Pecs 350
Large-scale testing (Phase 3)Study completedNCT03518047
What this trial is testing

Risankizumab Therapy Versus Placebo for Subjects With Psoriasis in the Russian Federation

Who this might be right for
Psoriasis
AbbVie 50
Not applicableNot Yet RecruitingNCT07481019
What this trial is testing

A Randomised Controlled Trial of ePROM-Guided Flexible Scheduling in Dermatology

Who this might be right for
Chronic Dermatological ConditionsEczemaUrticaria+2 more
National University Hospital, Singapore 250
Early research (Phase 1)Study completedNCT05523011
What this trial is testing

Safety and Tolerability Study of MSC Exosome Ointment

Who this might be right for
Psoriasis
Paracrine Therapeutics Dermatology Pte. Ltd. 10
Post-approval studies (Phase 4)Looking for participantsNCT07141004
What this trial is testing

Guselkumab Administered Subcutaneously in Treatment of Indian Participants With Psoriatic Arthritis (PsA)

Who this might be right for
Arthritis, Psoriatic
Johnson & Johnson Private Limited 100
Testing effectiveness (Phase 2)WithdrawnNCT02475304
What this trial is testing

Proof-of-concept Study of Forward Pharma (FP)187 in Patients With Mild/Moderate Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
Skane University Hospital
Testing effectiveness (Phase 2)Study completedNCT00143806
What this trial is testing

Transitioning From Cyclosporine to Alefacept in Psoriasis

Who this might be right for
Psoriasis
University of Medicine and Dentistry of New Jersey 13
Not applicableEnded earlyNCT01156532
What this trial is testing

Clinical Effectiveness and Impact on Health-related Quality of Life in Peruvian Patients With Psoriasis After 16 Weeks of Adalimumab Therapy

Who this might be right for
Moderate to Severe Psoriasis
AbbVie (prior sponsor, Abbott) 30
Not applicableStudy completedNCT00725452
What this trial is testing

Five-Year Observation of Remicade Treatment for Plaque Psoriasis in Austria (Study P04900)

Who this might be right for
Psoriasis
Merck Sharp & Dohme LLC 26
Not applicableLooking for participantsNCT07298265
What this trial is testing

Physician- vs Questionnaire-Based Screening for Psoriatic Arthritis in Psoriasis

Who this might be right for
Psoriasis (PsO)Psoriatic Arthritis (PsA)
Charite University, Berlin, Germany 500
Very early researchUnknownNCT03415165
What this trial is testing

Efficacy of Green Tea Buccal Tablets in Oral Lichen Planus

Who this might be right for
Oral Lichen Planus
Cairo University 60
Testing effectiveness (Phase 2)Study completedNCT00384098
What this trial is testing

Safety and Efficacy of Topically Applied CTA018 in Plaque Psoriasis

Who this might be right for
Psoriasis
OPKO Health, Inc. 140
Post-approval studies (Phase 4)Study completedNCT05510063
What this trial is testing

Pharmacokinetics, Efficacy, Safety, and Immunogenicity of SB5 Versus Humira in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Samsung Bioepis Co., Ltd. 371
Next Page